# Changshu Ximaide opens advanced drug delivery device R&D and manufacturing base

Changshu Ximaide's advanced drug delivery device R&D and manufacturing base opened in Changshu Economic Development Zone on August 6, 2024. The project, with a total investment of CNY 500 million, includes a 30,000-square-meter GMP factory, R&D center, and headquarters, designed to produce 50 million drug delivery devices annually.

- Type: New facility
- Announced: 2024-08-07
- Where: Changshu, Jiangsu, China
- Value: $69.4M (500.0M CNY)
- Starts operating: 6 Aug 2024
- Status: completed
- Capacity: 50 million drug delivery devices per year
- Products: drug delivery devices, dry powder inhalers, soft mist inhalers, nasal spray devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Changshu Ximaide](https://endata.com/companies/79050.md)

## Sources

- [changshu.gov.cn](https://www.changshu.gov.cn/zgcs/c100293/202408/33c90c211e024272b51f88f8a908fae5.shtml), 2024-08-07: "常熟新劢德先进药物递送装置研发与制造基地项目开业仪式在常熟经开区举行。"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.